Penn Medicine Healthy Heart

Last updated: April 17, 2025
Sponsor: University of Pennsylvania
Overall Status: Active - Recruiting

Phase

N/A

Condition

Circulation Disorders

Vascular Diseases

Williams Syndrome

Treatment

Penn Med Healthy Heart Program

Clinical Study ID

NCT06062394
851832
  • Ages 35-80
  • All Genders

Study Summary

To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll a program that will be evaluated in a clinical trial that is focused on changing patient behavior and powered to detect differences in improving blood pressure and cholesterol over 6 months for Penn Medicine patients in West/Southwest Philadelphia and Lancaster.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • On the Penn Medicine Primary Care Service Line registry

  • Last 2 Blood Pressure readings with Systolic Blood Pressure >=140 from anyoutpatient encounter in the last 12 months AND

  • ASCVD dx OR ASCVD risk score ≥10% OR Diabetes dx OR A1c ≥6.5 in last year ORDiabetes registry OR Last LDL ≥190 in past five years AND

  • Not on a statinor PCSK9, Inclisiran OR on a Low-intensity/moderate-intensity statin)with LDL >100

Exclusion

Exclusion Criteria:

  • Patients on PCSK9 inhibitors

  • Documented statin allergy/ or intolerance in the EMR

  • Pregnancy

  • Breast feeding

  • Markedly shortened life expectancy including:

  1. metastatic cancer

  2. hospice

  3. End Stage Renal Disease

  4. Congestive Heart Failure

  5. Dementia

  • Is a non-English speaker requiring a translator

  • Patients who do not have a cell phone

Study Design

Total Participants: 1980
Treatment Group(s): 1
Primary Treatment: Penn Med Healthy Heart Program
Phase:
Study Start date:
March 11, 2024
Estimated Completion Date:
April 30, 2026

Study Description

To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll Penn Medicine primary care patients into the Penn Medicine Healthy Heart, a six-month program for reduction of hypertension and hypercholesterolemia grounded in behavioral economics insights to increase uptake of and adherence to evidence-based interventions to reduce ASCVD risk. Penn Medicine Healthy Heart emphasizes proactive outreach and prevention outside of a traditional visit model using data assets to identify and risk stratify patients. The program aims to relieve overburdened PCPs through automated hovering technology coupled with a centralized, leveraged team of non-clinical navigators and nurse practitioners. The clinical trial will assess Penn Medicine Healthy Heart and will be powered to detect differences in improving blood pressure and cholesterol over 6 months for Penn Medicine patients in West/Southwest/Downtown Philadelphia and Lancaster, PA.

Connect with a study center

  • Penn Medicine

    Philadelphia, Pennsylvania 19104
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.